Insider Trading March 23, 2026

Ouster Director Executes Pre-Planned Sale of $33,900 in Shares Amid Strong Quarterly Results

Small, rule-based disposition by Ted L. Tewksbury III coincides with the company’s revenue and margin beats and renewed analyst interest

By Priya Menon OUST
Ouster Director Executes Pre-Planned Sale of $33,900 in Shares Amid Strong Quarterly Results
OUST

Ouster director Ted L. Tewksbury III sold 1,695 shares on March 19, 2026 under a Rule 10b5-1 plan, totaling $33,900. The sale occurred as the company reported fourth-quarter revenue and margin results that outperformed consensus estimates and drew positive analyst responses. After the transaction, Tewksbury directly holds 121,969 shares.

Key Points

  • Director Ted L. Tewksbury III sold 1,695 shares on March 19, 2026 at $20.00 per share, totaling $33,900.
  • Transaction executed under a Rule 10b5-1 trading plan dated August 12, 2025; sales included those for tax planning purposes.
  • Ouster reported approximately $62 million in fourth-quarter revenue, roughly 60% GAAP gross margin, and EPS of $0.06, all beating consensus; Cantor Fitzgerald reiterated Overweight and Oppenheimer raised its price target to $40.

Ouster, Inc. (NASDAQ: OUST) reported a director-level sale of company stock this week when Ted L. Tewksbury III sold 1,695 shares of common stock on March 19, 2026, according to a Form 4 filing with the Securities and Exchange Commission.

The shares were disposed of at $20.00 per share, producing a total transaction value of $33,900. The filing notes that the sale was carried out within the parameters of a pre-arranged Rule 10b5-1 trading plan dated August 12, 2025, and that some of the sales were made for tax planning purposes.

Following the transaction, Tewksbury’s direct ownership in Ouster stands at 121,969 shares. At the time of reporting, the company’s stock was trading at $21.18, a price that represents an 81% gain over the past year while reflecting a 39% decline over the previous six months.


Recent corporate results and analyst response

Separately from the insider filing, Ouster disclosed fourth-quarter financial results that materially exceeded consensus expectations. The company reported revenue of approximately $62 million, compared with the Visible Alpha consensus estimate of $41.2 million. On profitability metrics, Ouster’s GAAP gross margin came in at about 60%, well above the consensus figure of 36%.

Ouster’s earnings per share for the quarter were $0.06, outperforming a consensus forecast that had expected a loss of $0.14 per share. Those stronger-than-expected results prompted analyst activity: Cantor Fitzgerald reiterated an Overweight rating on the company, and Oppenheimer raised its price target on Ouster to $40, citing progress in software and contributions from the Stereolabs acquisition. The company’s first-quarter fiscal 2026 guidance also exceeded expectations, which the filing and analyst commentary indicate has bolstered investor confidence.

Context and implications

The director sale was processed under a previously established trading plan and noted as including transactions for tax planning. The amount sold is small relative to the director’s remaining holdings and to the company’s outstanding shares, while the quarter’s results and subsequent analyst actions underline a period of notable operational and financial performance for Ouster as reflected in revenue, margins, and guidance.

Because the Form 4 identifies the sale as governed by a Rule 10b5-1 plan, the timing of the trades was pre-determined under that arrangement rather than representing an ad hoc decision by the director.


Note: This article presents the transaction details and company results as disclosed in the referenced filings and announcements.

Risks

  • Insider selling under a predefined 10b5-1 plan limits inference about management sentiment - markets may interpret the sale in different ways, impacting market perception and share liquidity.
  • The company’s stock has shown significant volatility, trading 81% higher over the past year but down 39% in the last six months, indicating potential short-term price risk for investors.
  • Reliance on forward guidance and analyst outlooks introduces uncertainty if future quarters fail to meet elevated expectations, potentially affecting investor confidence.

More from Insider Trading

325 Capital and Affiliates Sell APEI Shares in $8.7M Disposition Mar 23, 2026 Alignment Healthcare CEO Disposes $2.06 Million in Stock Mar 23, 2026 Gap CFO Disposes of $278,488 in Stock as Company Reports In-Line Q4 Results Mar 23, 2026 WEX Chief Accounting Officer Disposes of $15,356 in Shares Under 10b5-1 Plan Mar 23, 2026 Dolphin Entertainment CEO Acquires 3,100 Shares in Small Insider Purchase Mar 23, 2026